Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Iselin, NJ
SEC filing record 1 source field available
Fiscal year end
30 September
Outlook Therapeutics, Inc. has filed 832 SEC EDGAR filings since 10 Aug 2015

SEC filing history

Showing 601-625 of 832 matching filings.

Per page
25
Current page
25
4

FORM 4 SUBMISSION

Filing date
13 Nov 2018
Reporting date
09 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Nov 2018
Reporting date
07 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-89495

AMENDMENT NO. 4 TO SCHEDULE 13D

Filing date
09 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

FORM 8-K

Filing date
09 Nov 2018
Reporting date
05 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

FORM 8-K

Filing date
30 Oct 2018
Reporting date
24 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89495

SCHEDULE 13G, AMENDMENT NO. 2

Filing date
26 Oct 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

FORM 8-K

Filing date
26 Oct 2018
Reporting date
22 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Oct 2018
Reporting date
22 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Oct 2018
Reporting date
22 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Oct 2018
Reporting date
30 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Sep 2018
Reporting date
21 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Sep 2018
Reporting date
21 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Sep 2018
Reporting date
21 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Sep 2018
Reporting date
21 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

FORM 8-K

Filing date
24 Sep 2018
Reporting date
21 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Sep 2018
Reporting date
18 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

FORM 8-K

Filing date
04 Sep 2018
Reporting date
28 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37759

DEFINITIVE PROXY STATEMENT

Filing date
17 Aug 2018
Reporting date
21 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

FORM 8-K

Filing date
14 Aug 2018
Reporting date
14 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-37759

PRELIMINARY PROXY STATEMENT

Filing date
07 Aug 2018
Reporting date
21 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Aug 2018
Reporting date
01 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

FORM 8-K

Filing date
03 Aug 2018
Reporting date
01 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Jul 2018
Reporting date
18 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-89495

AMENDMENT NO. 3

Filing date
20 Jul 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .